after the event. Considering all of these variables, our ultimate goal would be to determine the difference between the RBC count (and particularly the lowest limit of this) and RBC clearance for those who are truly SAH-positive vs. SAH-negative. Though I sense that we'll probably never know the complete answer, the work of Gorchyniski et al gives us a better understanding than we had before. Iapplaud and thank the authors for their efforts and analysis. And while a larger sample size, as they suggest, would be nice, as it is with most observational studies, the devil is in the denominator, and defining what we don't know is as important as determining what we do know. We'll just have to look forward to a well-designed prospective study and, in the meantime, at least understand that a negative CT does NOT finish the evaluation in someone with a suspicious history for SAH. And if there are RBCs in the CSF.....well, as they say, that's why they pay us the big bucks!
J. Toscano, MD San Ramon Regional Medical Center San Ramon, CA In reply:
The comments by J. Toscano are applicable to this difficult question that emergency medicine physicians continue to face: Who can we safely send home with a normal head CT and red blood cells in the CSF? Dr. Toscano's appraisal of the paper is valid and well articulated. His suggestion for future studies in defining with certainty what patients truly have a subarachnoid hemorrhage (SAH) with a reported "radiographically normal CT" and red blood cells in the CSF are defensible. I question if an exact cutoff value or specific range of CSF red blood cells are required to diagnose a SAH that is clinically insignificant.
While future prospective studies may be able to define exactly what constitutes a traumatic tap versus one consistent with a SAH as supported by MRI/MRA or angiography the next critical question would be the clinical significance of the SAH. A prospective observational study in those patients who have a radiographically normal CT with CSF red blood cells who are discharged home or admitted for observation with six month follow up may answer this question. If those patients who truly had a SAH were sent home with a radiographically normal CT and red blood cells in the CSF, was the SAH of clinical significance? And is there a need to utilize expensive and invasive imaging modalities to find evidence of a SAH that is of no clinical importance?
Julie Gorchynski, MD, MSc Christus-Spohn Memorial Hospital Corpus Christi, TX 
